| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Vascular Biology, The Picower Institute for Medical Research, Manhasset, New York 11030, USA; and
* University of Tübingen, Tübingen, Germany
2Correspondence: The Picower Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030, USA. E-mail: cmetz{at}picower.edu
Angiogenesis is an ordered process requiring the inter-play of numerous cellular and humoral factors. Studies over the past 20 years have identified several growth factors, cytokines, and enzymes that promote blood vessel formation. Most have revealed how individual factors promote an angiogenic phenotype in endothelial cells in vitro or contribute to blood vessel formation in vivo. However, the fundamental question that remains unanswered is how the cellular microenvironment contributes to angiogenesis. Fibrocytes are a recently characterized mesenchymal cell type isolated from peripheral blood that rapidly enter subcutaneously implanted wound chambers and sites of tissue injury. Here we describe the induction of an angiogenic phenotype in microvascular endothelial cells in vitro and promotion of angiogenesis in vivo by cultured fibrocytes. Fibrocytes constitutively secrete extracellular matrix-degrading enzymes, primarily matrix metalloproteinase 9, which promotes endothelial cell invasion. In addition, fibrocytes secrete several proangiogenic factors including VEGF, bFGF, IL-8, PDGF, and hematopoietic growth factors that promote endothelial cell migration, proliferation, and/or tube formation. By contrast, they do not produce representative antiangiogenic factors. Finally, both autologous fibrocytes and fibrocyte-conditioned media were found to induce blood vessel formation in vivo using the Matrigel angiogenesis model.—Hartlapp, I., Abe, R., Saeed, R. W., Peng, T., Voelter, W., Bucala, R., Metz, C. N. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo.
Key Words: fibroblast • antigen • MMP-9 • wound healing • neovascularization
This article has been cited by other articles:
|
|
 |
|
  C.-H. Wang, C.-D. Huang, H.-C. Lin, K.-Y. Lee, S.-M. Lin, C.-Y. Liu, K.-H. Huang, Y.-S. Ko, K. F. Chung, and H.-P. Kuo Increased Circulating Fibrocytes in Asthma with Chronic Airflow Obstruction Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M A. El-Asrar, S Struyf, J Van Damme, and K Geboes Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes Br. J. Ophthalmol., May 1, 2008; 92(5): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Spiekerkoetter, C. M. Alvira, Y.-M. Kim, A. Bruneau, K. L. Pricola, L. Wang, N. Ambartsumian, and M. Rabinovitch Reactivation of {gamma}HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L276 - L289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, H. Jiao, T. L. Stewart, M. V. H. Lyons, H. A. Shankowsky, P. G. Scott, and E. E. Tredget Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes J. Leukoc. Biol., December 1, 2007; 82(6): 1554 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Gomperts and R. M. Strieter Fibrocytes in lung disease J. Leukoc. Biol., September 1, 2007; 82(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pilling, N. M. Tucker, and R. H. Gomer Aggregated IgG inhibits the differentiation of human fibrocytes J. Leukoc. Biol., June 1, 2006; 79(6): 1242 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Davie, E. V. Gerasimovskaya, S. E. Hofmeister, A. P. Richman, P. L. Jones, J. T. Reeves, and K. R. Stenmark Pulmonary Artery Adventitial Fibroblasts Cooperate with Vasa Vasorum Endothelial Cells to Regulate Vasa Vasorum Neovascularization: A Process Mediated by Hypoxia and Endothelin-1 Am. J. Pathol., June 1, 2006; 168(6): 1793 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Frid, J. A. Brunetti, D. L. Burke, T. C. Carpenter, N. J. Davie, J. T. Reeves, M. T. Roedersheimer, N. van Rooijen, and K. R. Stenmark Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage Lineage Am. J. Pathol., February 1, 2006; 168(2): 659 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Choi, E M Pierce, C Jakubzick, K J Carpenter, S L Kunkel, H Evanoff, F J Martinez, K R Flaherty, B B Moore, G B Toews, et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia J. Clin. Pathol., January 1, 2006; 59(1): 28 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Stenmark, N. J. Davie, J. T. Reeves, and M. G. Frid Hypoxia, leukocytes, and the pulmonary circulation J Appl Physiol, February 1, 2005; 98(2): 715 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pilling, C. D. Buckley, M. Salmon, and R. H. Gomer Inhibition of Fibrocyte Differentiation by Serum Amyloid P J. Immunol., November 15, 2003; 171(10): 5537 - 5546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. C. Hendrix, R. E. B. Seftor, E. A. Seftor, L. M. Gruman, L. M. L. Lee, B. J. Nickoloff, L. Miele, D. D. Sheriff, and G. C. Schatteman Transendothelial Function of Human Metastatic Melanoma Cells: Role of the Microenvironment in Cell-Fate Determination Cancer Res., February 1, 2002; 62(3): 665 - 668. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
